Cargando…

Recent Updates on Treatment of Ocular Microbial Infections by Stem Cell Therapy: A Review

Ocular microbial infection has emerged as a major public health crisis during the past two decades. A variety of causative agents can cause ocular microbial infections; which are characterized by persistent and destructive inflammation of the ocular tissue; progressive visual disturbance; and may re...

Descripción completa

Detalles Bibliográficos
Autores principales: Teh, Seoh Wei, Mok, Pooi Ling, Abd Rashid, Munirah, Bastion, Mae-Lynn Catherine, Ibrahim, Normala, Higuchi, Akon, Murugan, Kadarkarai, Mariappan, Rajan, Subbiah, Suresh Kumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5855780/
https://www.ncbi.nlm.nih.gov/pubmed/29438279
http://dx.doi.org/10.3390/ijms19020558
_version_ 1783307177213034496
author Teh, Seoh Wei
Mok, Pooi Ling
Abd Rashid, Munirah
Bastion, Mae-Lynn Catherine
Ibrahim, Normala
Higuchi, Akon
Murugan, Kadarkarai
Mariappan, Rajan
Subbiah, Suresh Kumar
author_facet Teh, Seoh Wei
Mok, Pooi Ling
Abd Rashid, Munirah
Bastion, Mae-Lynn Catherine
Ibrahim, Normala
Higuchi, Akon
Murugan, Kadarkarai
Mariappan, Rajan
Subbiah, Suresh Kumar
author_sort Teh, Seoh Wei
collection PubMed
description Ocular microbial infection has emerged as a major public health crisis during the past two decades. A variety of causative agents can cause ocular microbial infections; which are characterized by persistent and destructive inflammation of the ocular tissue; progressive visual disturbance; and may result in loss of visual function in patients if early and effective treatments are not received. The conventional therapeutic approaches to treat vision impairment and blindness resulting from microbial infections involve antimicrobial therapy to eliminate the offending pathogens or in severe cases; by surgical methods and retinal prosthesis replacing of the infected area. In cases where there is concurrent inflammation, once infection is controlled, anti-inflammatory agents are indicated to reduce ocular damage from inflammation which ensues. Despite advances in medical research; progress in the control of ocular microbial infections remains slow. The varying level of ocular tissue recovery in individuals and the incomplete visual functional restoration indicate the chief limitations of current strategies. The development of a more extensive therapy is needed to help in healing to regain vision in patients. Stem cells are multipotent stromal cells that can give rise to a vast variety of cell types following proper differentiation protocol. Stem cell therapy shows promise in reducing inflammation and repairing tissue damage on the eye caused by microbial infections by its ability to modulate immune response and promote tissue regeneration. This article reviews a selected list of common infectious agents affecting the eye; which include fungi; viruses; parasites and bacteria with the aim of discussing the current antimicrobial treatments and the associated therapeutic challenges. We also provide recent updates of the advances in stem cells studies on sepsis therapy as a suggestion of optimum treatment regime for ocular microbial infections.
format Online
Article
Text
id pubmed-5855780
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-58557802018-03-20 Recent Updates on Treatment of Ocular Microbial Infections by Stem Cell Therapy: A Review Teh, Seoh Wei Mok, Pooi Ling Abd Rashid, Munirah Bastion, Mae-Lynn Catherine Ibrahim, Normala Higuchi, Akon Murugan, Kadarkarai Mariappan, Rajan Subbiah, Suresh Kumar Int J Mol Sci Review Ocular microbial infection has emerged as a major public health crisis during the past two decades. A variety of causative agents can cause ocular microbial infections; which are characterized by persistent and destructive inflammation of the ocular tissue; progressive visual disturbance; and may result in loss of visual function in patients if early and effective treatments are not received. The conventional therapeutic approaches to treat vision impairment and blindness resulting from microbial infections involve antimicrobial therapy to eliminate the offending pathogens or in severe cases; by surgical methods and retinal prosthesis replacing of the infected area. In cases where there is concurrent inflammation, once infection is controlled, anti-inflammatory agents are indicated to reduce ocular damage from inflammation which ensues. Despite advances in medical research; progress in the control of ocular microbial infections remains slow. The varying level of ocular tissue recovery in individuals and the incomplete visual functional restoration indicate the chief limitations of current strategies. The development of a more extensive therapy is needed to help in healing to regain vision in patients. Stem cells are multipotent stromal cells that can give rise to a vast variety of cell types following proper differentiation protocol. Stem cell therapy shows promise in reducing inflammation and repairing tissue damage on the eye caused by microbial infections by its ability to modulate immune response and promote tissue regeneration. This article reviews a selected list of common infectious agents affecting the eye; which include fungi; viruses; parasites and bacteria with the aim of discussing the current antimicrobial treatments and the associated therapeutic challenges. We also provide recent updates of the advances in stem cells studies on sepsis therapy as a suggestion of optimum treatment regime for ocular microbial infections. MDPI 2018-02-13 /pmc/articles/PMC5855780/ /pubmed/29438279 http://dx.doi.org/10.3390/ijms19020558 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Teh, Seoh Wei
Mok, Pooi Ling
Abd Rashid, Munirah
Bastion, Mae-Lynn Catherine
Ibrahim, Normala
Higuchi, Akon
Murugan, Kadarkarai
Mariappan, Rajan
Subbiah, Suresh Kumar
Recent Updates on Treatment of Ocular Microbial Infections by Stem Cell Therapy: A Review
title Recent Updates on Treatment of Ocular Microbial Infections by Stem Cell Therapy: A Review
title_full Recent Updates on Treatment of Ocular Microbial Infections by Stem Cell Therapy: A Review
title_fullStr Recent Updates on Treatment of Ocular Microbial Infections by Stem Cell Therapy: A Review
title_full_unstemmed Recent Updates on Treatment of Ocular Microbial Infections by Stem Cell Therapy: A Review
title_short Recent Updates on Treatment of Ocular Microbial Infections by Stem Cell Therapy: A Review
title_sort recent updates on treatment of ocular microbial infections by stem cell therapy: a review
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5855780/
https://www.ncbi.nlm.nih.gov/pubmed/29438279
http://dx.doi.org/10.3390/ijms19020558
work_keys_str_mv AT tehseohwei recentupdatesontreatmentofocularmicrobialinfectionsbystemcelltherapyareview
AT mokpooiling recentupdatesontreatmentofocularmicrobialinfectionsbystemcelltherapyareview
AT abdrashidmunirah recentupdatesontreatmentofocularmicrobialinfectionsbystemcelltherapyareview
AT bastionmaelynncatherine recentupdatesontreatmentofocularmicrobialinfectionsbystemcelltherapyareview
AT ibrahimnormala recentupdatesontreatmentofocularmicrobialinfectionsbystemcelltherapyareview
AT higuchiakon recentupdatesontreatmentofocularmicrobialinfectionsbystemcelltherapyareview
AT murugankadarkarai recentupdatesontreatmentofocularmicrobialinfectionsbystemcelltherapyareview
AT mariappanrajan recentupdatesontreatmentofocularmicrobialinfectionsbystemcelltherapyareview
AT subbiahsureshkumar recentupdatesontreatmentofocularmicrobialinfectionsbystemcelltherapyareview